InsiderClue
Insiders · Profile

AGARWAL SUNIL

EVP, Head of Development & CMO at Sana Biotechnology · Chief Medical Officer at Ultragenyx Pharmaceutical. Filing since 20 Aug 2015. CIK 0001616640

SANA Sana Biotechnology, Inc. EVP, Head of Development & CMO · 2 trades RARE Ultragenyx Pharmaceutical Inc. Chief Medical Officer · 12 trades
Company
Date
Role
Action
Shares
Amount
Of holding
SANA Sana Biotechnology, Inc.
16 Sep 2021
EVP, Head of Development & CMO
Sold, plan not stated
1,627
$42.30K
0.1%
SANA Sana Biotechnology, Inc.
15 Sep 2021
EVP, Head of Development & CMO
Sold, plan not stated
58,373
$1.52M
3.6%
RARE Ultragenyx Pharmaceutical Inc.
21 Jul 2016
Chief Medical Officer
Sold, plan not stated
649
$34.19K
6.4%
RARE Ultragenyx Pharmaceutical Inc.
20 Jun 2016
Chief Medical Officer
Sold, plan not stated
650
$35.20K
5.8%
RARE Ultragenyx Pharmaceutical Inc.
24 May 2016
Chief Medical Officer
Sold, plan not stated
650
$42.90K
8.4%
RARE Ultragenyx Pharmaceutical Inc.
20 Apr 2016
Chief Medical Officer
Sold, plan not stated
649
$45.77K
7.0%
RARE Ultragenyx Pharmaceutical Inc.
22 Mar 2016
Chief Medical Officer
Sold, plan not stated
650
$39.94K
6.3%
RARE Ultragenyx Pharmaceutical Inc.
22 Feb 2016
Chief Medical Officer
Sold, plan not stated
658
$41.77K
5.8%
RARE Ultragenyx Pharmaceutical Inc.
20 Jan 2016
Chief Medical Officer
Sold, plan not stated
585
$42.61K
4.6%
RARE Ultragenyx Pharmaceutical Inc.
22 Dec 2015
Chief Medical Officer
Sold, plan not stated
498
$57.18K
3.6%
RARE Ultragenyx Pharmaceutical Inc.
23 Nov 2015
Chief Medical Officer
Sold, plan not stated
498
$47.75K
3.5%
RARE Ultragenyx Pharmaceutical Inc.
20 Oct 2015
Chief Medical Officer
Sold, plan not stated
649
$55.50K
4.2%
RARE Ultragenyx Pharmaceutical Inc.
22 Sep 2015
Chief Medical Officer
Sold, plan not stated
498
$54.54K
3.0%
RARE Ultragenyx Pharmaceutical Inc.
20 Aug 2015
Chief Medical Officer
Sold, plan not stated
17,020
$1.89M
50.2%
14 decisions on file.